We bring together individuals with the KRAS-variant to share their stories, learn from one other, and offer support.
The holiday season is a time of remembrance. We relive our favorite memories around the dinner table, exchange gifts with those who helped make them, and mourn those no longer with us. This December, Cathy Ledvina has an extraordinary milestone to commemorate: her sixteenth year as a breast cancer survivor.read more
Amidst the setbacks and complexities of their research, the team works diligently toward the goal of expanding and improving our understanding of how cancer works and how it can be treated. I posed some questions to a few of the researchers in the Weidhaas research group.read more
Many of you may know that 1 in 8 women will be diagnosed with breast cancer in her lifetime. With those startling statistics, it’s almost a guarantee this disease will touch all of us in some way. Perhaps you have been diagnosed with breast cancer yourself, years ago or within the last few months. Or perhaps you are one of the 7 in 8 who will avoid it, but your mother, best friend, colleague, aunt, or spouse will not.read more
For the large majority of us who suffer one or more symptoms of menopause, we can all agree that it is NO FUN. So what can we do about it? According to the North American Menopause Society (NAMS), a leading group of health care providers who specialize in health issues for women at perimenopause and beyond, hormone replacement therapy (also known as estrogen replacement therapy or hormone therapy) remains the most effective treatment for the symptoms of menopause. But wait! Isn’t hormone replacement therapy bad for you?read more
Cancer survivors and their loved ones are no strangers to the adverse effects chemotherapy can have on one’s body, mind, and spirit. Despite these setbacks, Mirakind community member and blogger, Heather Trojan, refuses to let her cancer treatment lead her to a toxic life. Diagnosed with breast cancer in October 2011, Heather believes that “self care” is not “selfish,” but rather noticed the correlation between a particularly stressful time in her life and when her doctor believes the cancer first erupted.read more
Joanne Weidhaas is MiraKind’s founder and one of the scientists responsible for discovering the KRAS-variant, an inherited genetic mutation which predicts an increased risk of cancer. Following this breakthrough, Weidhaas and her team of researchers began exploring the connection between estrogen and breast cancer risk, particularly as it pertains to individuals who test positive for the KRAS-variant.read more